Cases 41 - 50 of 372
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2023cv00551
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2023cv00448
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Cipla Limited et al
as 1:2023cv00389
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Keryx Biopharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00331
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. Cipla Ltd. et al
as 1:2023cv00287
Plaintiff:
Exelixis, Inc.
Defendant:
Cipla Ltd. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Hikma Pharmaceuticals USA Inc. et al v. Annora Pharma Private Limited
as 1:2023cv00231
Plaintiff:
Hikma Pharmaceuticals USA Inc. and Hikma International Pharmaceuticals LLC
Defendant:
Annora Pharma Private Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Exela Pharma Sciences, LLC v. Hikma Pharmaceuticals USA Inc.
as 1:2023cv00137
Plaintiff:
Exela Pharma Sciences, LLC
Defendant:
Nivagen Pharmaceuticals, Inc. and Hikma Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al
as 1:2023cv00039
Plaintiff:
Merck KGaA, Merck Serono SA and Ares Trading SA
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
